- Home
- TLSI vs POWW Comparison
TLSI vs POWW Comparison
Compare TLSI & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- POWW
- Stock Information
- Founded
- TLSI 2010
- POWW 1990
- Country
- TLSI United States
- POWW United States
- Employees
- TLSI N/A
- POWW N/A
- Industry
- TLSI Medical Specialities
- POWW Ordnance And Accessories
- Sector
- TLSI Health Care
- POWW Industrials
- Exchange
- TLSI Nasdaq
- POWW Nasdaq
- Market Cap
- TLSI 150.0M
- POWW 131.2M
- IPO Year
- TLSI N/A
- POWW N/A
- Fundamental
- Price
- TLSI $3.94
- POWW $1.25
- Analyst Decision
- TLSI Strong Buy
- POWW Buy
- Analyst Count
- TLSI 5
- POWW 2
- Target Price
- TLSI $10.90
- POWW $1.75
- AVG Volume (30 Days)
- TLSI 73.5K
- POWW 462.0K
- Earning Date
- TLSI 08-12-2025
- POWW 08-08-2025
- Dividend Yield
- TLSI N/A
- POWW N/A
- EPS Growth
- TLSI N/A
- POWW N/A
- EPS
- TLSI N/A
- POWW N/A
- Revenue
- TLSI $35,990,000.00
- POWW $45,280,898.00
- Revenue This Year
- TLSI $55.39
- POWW $9.54
- Revenue Next Year
- TLSI $54.89
- POWW N/A
- P/E Ratio
- TLSI N/A
- POWW N/A
- Revenue Growth
- TLSI 45.50
- POWW 76.12
- 52 Week Low
- TLSI $3.42
- POWW $0.95
- 52 Week High
- TLSI $6.04
- POWW $2.14
- Technical
- Relative Strength Index (RSI)
- TLSI 39.84
- POWW 51.28
- Support Level
- TLSI $3.42
- POWW $1.11
- Resistance Level
- TLSI $4.00
- POWW $1.29
- Average True Range (ATR)
- TLSI 0.36
- POWW 0.07
- MACD
- TLSI -0.01
- POWW 0.02
- Stochastic Oscillator
- TLSI 34.75
- POWW 73.68
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.